AuntMinnie

MARCH 5, 2025

TerraPower recently shipped its first batch ofAc-225 through the project, and boasts more than 10 supply agreements with radiopharmaceutical developers in the U.S., So, if you do that math, it's about 90,000 millicuries per year that we would expect to be harvesting once our supply chain is at scale, he said. Canada, Australia, and in Europe.

Nuclear Medicine 200

Nuclear Medicine Radiopharmaceuticals IT Clinic 200

AuntMinnie

NOVEMBER 12, 2024

Middlebrooks, MD, Mayo Clinic, Jacksonville, FL Erik H. Middlebrooks, MD, of the Mayo Clinic in Jacksonville, FL. Given the extensive array of sequences and techniques employed in clinical imaging, we must address the inherent challenges associated with each," he noted. Middlebrooks, MD. from Ukraine.

Radiologist 360

Radiologist Education Clinic Radiology 360

AuntMinnie

JUNE 8, 2023

Radiopharmaceutical manufacturer SpectronRx and nuclear medicine drug distributo.

Radiopharmaceuticals 130

Radiopharmaceuticals Nuclear Medicine Clinic 130

AuntMinnie

MARCH 25, 2025

Actinium will continue developing its lead radiopharmaceutical product Actimab-A, as well as additional early and late-stage development candidates for both U.S. and international clinical trials.

Pharmaceutical 130

Pharmaceutical Radiopharmaceuticals Clinic IT 130

AuntMinnie

NOVEMBER 20, 2024

The company has entered into asset purchase and exclusive worldwide in-license agreements for a suite of clinically validated FAP-targeting therapeutic and precision medicine radiopharmaceutical candidates.

Nuclear Medicine 130

Nuclear Medicine Pharmaceutical Radiopharmaceuticals Clinic 130

AuntMinnie

OCTOBER 14, 2024

These SSTRs can be targeted both with gallium-68 (Ga-68) imaging agents and therapeutic lutetium-177 (Lu-177) radiopharmaceuticals using a so-called theranostics approach. Meningiomas are the most common primary adult intracranial tumors and most meningiomas show high expression of somatostatin receptors (SSTRs). In the U.S.,

Nuclear Medicine 276

Nuclear Medicine Radiopharmaceuticals Insurance Clinic 276

AuntMinnie

FEBRUARY 26, 2025

The analysis might help to establish a model for balancing clinical and environmental priorities in radiology departments globally. Late-phase imaging was performed when clinically indicated for liver or kidney conditions. SPECT and low-dose CT scans could be added for areas with suspected radiopharmaceutical uptake.

Bone Scan 130

Bone Scan Radiopharmaceuticals Imaging Modalities Bone Scintigraphy 130

AuntMinnie

MARCH 27, 2025

Pass-through payment status will allow the CMS to provide separate payments for the radiopharmaceutical and the PET-CT scan when performed with Flyrcado in the hospital outpatient setting. Flyrcado will be unveiled at the ACC conference on March 29.

Healthcare 130

Healthcare Healthcare Medicare Radiopharmaceuticals 130

AuntMinnie

JULY 12, 2024

Reshaping the hospital's nuclear medicine and radiopharmaceutical strategy toward theranostics involves intensive and inclusive planning, Beyder explained at SNMMI. Underwood led the nuclear medicine and radiopharmaceutical therapy team within radiation safety at Mayo Clinic and directly supports the program in Rochester.

Nuclear Medicine 264

Nuclear Medicine Radiation Oncology Radiopharmaceuticals Radiation 264

Imaging Technology

JANUARY 5, 2024

announced that it has entered into a patent license agreement with Mayo Clinic for the rights to the PSMA Alpha-PET DoubLET platform technology for the treatment of PSMA-expressing cancers, with an initial focus on prostate. milla1cf Fri, 01/05/2024 - 11:21 January 5, 2024 — Perspective Therapeutics, Inc.

Radiopharmaceuticals 104

Radiopharmaceuticals Clinic Nuclear Medicine Radiation 104

AuntMinnie

MAY 1, 2023

Blue Earth Diagnostics is highlighting results from a clinical study that ha. prostate radiopharmaceutical licensing Blue Earth to highlight PET study results at ASTRO Blue Earth wins FDA nod for PSMA-PET tracer NDA

Clinic 130

Clinic Radiopharmaceuticals Diagnostic 130

AuntMinnie

OCTOBER 20, 2024

Nuclidium has begun a phase I clinical trial evaluating the use of copper-61 (Cu-61) in patients with prostate-specific membrane antigen (PSMA)-positive prostate cancer. The radiopharmaceutical is called Cu-61 NuriPro and is part of the company's NuriPro program, it said.

Clinic 130

Clinic Radiopharmaceuticals Hospital Imaging 130

AuntMinnie

JUNE 3, 2024

With therapeutic radiopharmaceuticals coming to market quickly and available to smaller institutions around the U.S., My vision of a theranostic center includes a flagship facility that has a PET/CT scanner, a SPECT/CT scanner, and then multiple rooms for infusions of radiopharmaceuticals," Siegel explained.

Nuclear Medicine 264

Nuclear Medicine Radiopharmaceuticals Radiation Radiation Oncology 264

Imaging Technology

MAY 10, 2024

milla1cf Fri, 05/10/2024 - 08:08 May 10, 2024 — Mariana Oncology , a fully integrated biotechnology company pioneering a new era of radiopharmaceutical innovation to treat people with cancer , today announced it will be acquired by Novartis for $1 billion upfront and up to $750 million in potential milestone payments.

Radiopharmaceuticals 95

Radiopharmaceuticals Clinic IT 95

AuntMinnie

JUNE 11, 2024

TORONTO – The radiopharmaceutical Pluvicto improves progression-free survival in patients with metastatic prostate cancer who haven’t undergone taxane therapy, according to research presented at the SNMMI meeting. Oliver Sartor, MD The study, which was awarded SNMMI’s Abstract of the Year award, shared data from the phase III PSMAfore trial.

Nuclear Medicine 306

Nuclear Medicine Radiopharmaceuticals Radiograph Radiographer 306

Imaging Technology

OCTOBER 17, 2023

a clinical stage radiopharmaceutical company focused on the discovery and development of novel agents for the treatment of a wide range of oncology indications, is pleased to announce that the first subject has been dosed in its Phase 1 study of 68Ga-R8760. Gary Hammer , M.D.,

Radiopharmaceuticals 116

Radiopharmaceuticals Disease Clinic Diagnose 116

AuntMinnie

OCTOBER 25, 2024

Most Influential Radiology Researcher Erik Middlebrooks, MD, Mayo Clinic, Jacksonville, FL Erik Middlebrooks, MD. One of this year's nominations for Most Influential Radiology Researcher is Erik Middlebrooks, MD, of the Mayo Clinic in Jacksonville, FL.

Nuclear Medicine 358

Nuclear Medicine Education Radiology Technologist Radiation Science 358

AuntMinnie

APRIL 4, 2024

Life Molecular Imaging (LMI) and Sofie Biosciences have begun offering the Neuraceq ( florbetaben F-18) PET radiotracer produced at Sofie's radiopharmaceutical manufacturing site in Cleveland, Ohio. With this expansion, LMI continues driving commercial sales of Neuraceq around the U.S.

Radiopharmaceuticals 238

Radiopharmaceuticals Imaging Disease Diagnostic 238

AuntMinnie

FEBRUARY 11, 2025

United Theranostics has secured $15 million in funding from Old National Bank to expand its network of radiopharmaceutical therapy clinics for cancer treatment. The new clinics will be modeled after United Theranostics' founding site in Glen Burnie, MD, and its most recently opened facility in Princeton, NJ, it said.

Radiopharmaceuticals 147

Radiopharmaceuticals Clinic Medical IT 147

AuntMinnie

DECEMBER 8, 2023

Organizing pneumonia can hide underlying lung cancers in up to 10% of cases, and repeat imaging in the form of PET/CT -- and additional biopsy -- should be considered in patients with high clinical suspicion of malignancy, researchers have reported. The bottom line?

Imaging 309

Imaging Radiopharmaceuticals Disease Diagnose 309

AuntMinnie

NOVEMBER 1, 2024

In other radiology oriented provisions, the final rule also addresses payment for radiopharmaceuticals in physician offices.

Radiopharmaceuticals 213

Radiopharmaceuticals Medicare Computed Tomography Hospital 213

Imaging Technology

SEPTEMBER 20, 2023

a therapeutic oncology company and 3B Pharmaceuticals (3BP) GmbH, a biotechnology company developing targeted radiopharmaceutical drugs and diagnostics for cancer detection and treatment, announced an exclusive licensing agreement for RefleXion to develop and commercialize a specific 3BP molecule to direct its SCINTIX biology-guided radiotherapy.

Pharmaceutical 105

Pharmaceutical Radiopharmaceuticals Radiation Diagnostic 105

AuntMinnie

FEBRUARY 24, 2025

An open-source AI tool can help predict renal function decline in prostate cancer patients undergoing lutetium-177 (Lu-177) radiopharmaceutical therapy, according to a study published February 25 in Radiology.

Radiopharmaceuticals 291

Radiopharmaceuticals Disease Clinic Radiation 291

Imaging Technology

JULY 25, 2023

By leveraging our expertise in radiopharmaceuticals, we aim to contribute to the early detection and accurate monitoring of epithelial-derived cancers. This further strengthens our commitment to production and development of novel radiopharmaceuticals to advance cancer treatments and quality of life for cancer patients."

Radiopharmaceuticals 98

Radiopharmaceuticals Imaging Pharmaceutical Disease 98

AuntMinnie

MARCH 26, 2024

Food and Drug Administration's (FDA) approvals of radiopharmaceuticals for neuroendocrine tumors and then for prostate cancer, theranostics has picked up momentum in clinical practice, propelled by encouraging research. Since 2013 we've had several more radiopharmaceutical therapies get FDA approval. Since the U.S.

Nuclear Medicine 306

Nuclear Medicine Radiopharmaceuticals Radiation Health Science 306

Imaging Technology

APRIL 10, 2024

an investigational radiohybrid (rh) Prostate-Specific Membrane Antigen-targeted therapeutic radiopharmaceutical, is the lead candidate in Blue Earth Therapeutics’ oncology development program of next generation therapeutic radiopharmaceuticals. Our ongoing Phase 1/2 clinical trial ( NCT05413850 ) is evaluating 177Lu-rhPSMA-10.1

Radiopharmaceuticals 105

Radiopharmaceuticals Radiosensitivity Medical Diagnostic 105

Imaging Technology

JUNE 15, 2023

The clinical trial will use this investigational radiopharmaceutical to help understand if patients have CD8+ T cells in their tumors and will, therefore, be more likely to respond to immune checkpoint inhibitors, the main class of immunotherapies currently approved for use.

Radiopharmaceuticals 98

Radiopharmaceuticals Pharmaceutical Nuclear Medicine PET Scan 98

AuntMinnie

JUNE 20, 2024

MIBI-SPECT/CT is considered the standard technique for guiding these surgeries, yet several phase II clinical trials suggest advantages of a newer approach using FCH-PET, such as superior spatial resolution for detecting small adenomas and lower radiation exposure to patients, they noted. The full study is available here.

Radiopharmaceuticals 264

Radiopharmaceuticals Radiation Imaging Clinic 264

Imaging Technology

FEBRUARY 21, 2024

milla1cf Wed, 02/21/2024 - 18:58 February 21, 2024 — Blue Earth Therapeutics , a Bracco company and emerging leader in the development of innovative next generation therapeutic radiopharmaceuticals, is pleased to share the publication of promising early clinical data with 177Lu-rhPSMA-10.1 177Lu-rhPSMA-10.1 177Lu-rhPSMA-10.1

Clinic 104

Clinic Radiopharmaceuticals Nuclear Medicine Hospital 104

AuntMinnie

FEBRUARY 20, 2024

Blue Earth Therapeutics is highlighting early clinical results from a German trial investigating the use of a lutetium-177 (Lu-177)-labeled prostate specific antigen (PSMA) radiopharmaceutical. A phase I and II clinical trial assessing the safety, tolerability, dosimetry, and antitumor activity of Lu-177 rhPSMA-10.1

Clinic 100

Clinic Nuclear Medicine Radiopharmaceuticals Hospital 100

AuntMinnie

FEBRUARY 12, 2024

In patients treated at a memory clinic at Huashan Hospital in Shanghai, amyloid PET scans detected brain pathology associated with the disease and led to changes in treatment plans in 36.5% The clinical utility of amyloid PET scans has been systematically studied in many other countries. The full study is available here.

PET Scan 262

PET Scan Diagnose Disease Radiopharmaceuticals 262

AuntMinnie

JANUARY 17, 2025

The mutual aim of the collaboration is to jointly establish commercial supply chains that can be accessed by radiopharmaceutical drug developers for clinical trials and commercial applications, according to Nusano.

Radiopharmaceuticals 130

Radiopharmaceuticals Clinic Medical IT 130

Imaging Technology

JULY 11, 2023

We are delighted by our collaboration with Ratio Therapeutics in advancing the clinical development of RTX-1363S as a FAP-targeted diagnostic to the clinic," stated Etienne Montagut, Lantheus' Chief Business Officer. "By milla1cf Tue, 07/11/2023 - 09:02 July 11, 2023 — Ratio Therapeutics Inc.

Radiopharmaceuticals 75

Radiopharmaceuticals Imaging Pharmaceutical Disease 75

AuntMinnie

JUNE 5, 2024

NorthStar Medical Radioisotopes has completed a cleanroom facility at its campus in Beloit, WI, to support batch production of radiopharmaceuticals for research and treatment. The cleanroom at NorthStar's campus in Beloit, WI.

Radiopharmaceuticals 130

Radiopharmaceuticals Clinic Medical IT 130

AuntMinnie

MAY 22, 2024

Aktis Oncology has entered a potential $1 billion collaboration agreement with Eli Lilly to generate anticancer radiopharmaceuticals using its miniprotein technology platform. billion in potential preclinical, clinical, regulatory, and commercial milestones, as well as tiered royalties, it noted.

Radiopharmaceuticals 130

Radiopharmaceuticals Clinic IT 130

Imaging Technology

SEPTEMBER 8, 2023

milla1cf Fri, 09/08/2023 - 16:25 September 8, 2023 — Positron Corporation , a leading molecular imaging medical device company, is pleased to announce that the Company will begin its clinical study of its Affinity PET-CT imaging device with Ochsner Clinic Foundation in New Orleans, LA. on September 18, 2023.

Clinic 105

Clinic Medical Device Radiopharmaceuticals IT 105

AuntMinnie

JANUARY 3, 2024

NorthStar Medical Radioisotopes and Chester Springs, PA-based Curadh MTR have entered a strategic collaboration agreement to develop radiopharmaceuticals for the treatment of primary and metastatic solid tumors.

Radiopharmaceuticals 130

Radiopharmaceuticals Diagnostic Clinic Medical 130